Sustainability push lifts medical device reprocessing to $3.8b

Asia-Pacific is projected to be the fastest-growing region.

The global medical device reprocessing market is projected to grow to $3.8b by 2034, driven by hospitals adopting reprocessed devices to cut procurement costs.

In a report, DelveInsight said market growth is further supported by rising surgical volumes and growing sustainability mandates pushing healthcare systems toward circular-economy practices.

Advances in cleaning, sterilisation, and validation technologies have also strengthened clinical confidence that reprocessed devices meet new-device performance standards.

North America leads the market, holding approximately 43% of global revenue in 2025. The region's dominance is underpinned by the FDA's regulatory framework for single-use device reprocessing, which has built confidence in the practice among providers.

Europe holds the second-largest share at approximately 25%. Germany has operated under a regulated reprocessing framework for more than a decade, though proposed restrictions on reprocessing of CE-marked devices could affect future growth.

Asia-Pacific is projected to be the fastest-growing region, with a compound annual growth rate of 16.88% through 2034.

Growth is driven by expanding healthcare infrastructure, rising surgical volumes tied to an ageing population, and evolving regulatory support.

Japan has aligned its Quality Management System regulations to establish a formal pathway for reprocessed devices.

Meanwhile, China's hospital modernisation push targets 70% device-reuse certification in tier-1 cities by 2028, whilst India's Ayushman Bharat program is expected to make reprocessing a standard feature of government hospital procurement starting in 2026.